<DOC>
	<DOC>NCT00396175</DOC>
	<brief_summary>A clinical study to collect additional data in order to characterize the reduction in PSA with finasteride 1 mg, and its reversibility in men with androgenetic alopecia between the ages of 40 to 60 years.</brief_summary>
	<brief_title>Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<criteria>Inclusion Criteria : Men 40 to 60 years of age, and in good general physical and mental health, with androgenetic alopecia Exclusion Criteria : History of previous bladder surgery, acute urinary retention, urethral strictures, repeated urethral catheterizations, repeated urinary tract infections, or active urinary tract infections History of treatment with finasteride (PROSCAR or PROPECIA) or hypersensitivity to any component of finasteride.</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>